INPPL1 and in situ carcinoma: The level of SHIP2 protein in the liver of rats in the CIS group was markedly higher than that in the control group (Figure 5b, p < 0.001), whereas the level in the Xiaoyaosan or rosiglitazone group was significantly reduced (both p < 0.001).